A Safety and Immune Study of 2 Types of GlaxoSmithKline's Varicella Vaccines Given as a 2-doses Course to Healthy Children 12-23 Months of Age.

Clinical trial NCT02570126 · COMPLETED

Trial details

NCT number: NCT02570126
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chicken-pox Illness (Varicella Virus Disease)Chickenpox

Start date: 2015-11-13
Primary completion: 2016-10-25
Enrollment: 1236

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.